Enhance your practice with CME and tools that focus on diseases and conditions impacting the female patient.
From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies
Aditya Bardia, MD, MPH, FASCO
Erica L. Mayer, MD, MPH
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
Rapid Data Pulses From ASCO 2026: Emerging Data on Oral Targeted Strategies in Breast Cancer
Shared Goals, Shared Gains: Align With Patient Preferences
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
Minimal By Design: Define MSE Endpoints
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
When to Begin FcRn: Initiation Criteria, Key Evidence
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
22nd Annual Women’s Health Annual Visit (WHAV)
Multiple dates & locations available
Target Locked in gMG: Why T2T Matters
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
Precision Starts Before Birth: Reimagining Fetal Care Through FcRn Immune Modulation
Kenneth J. Moise Jr., MD
Kara B. Markham, MD
Primary Biliary Cholangitis: Shining Light on an "Invisible" Female Health Burden
Gideon Hirschfield, MB, BChir, PhD
Marlyn Mayo, MD
Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages
Alison Kole, MD, MPH, FACCP
Ghada Bourjeily, MD, FCCP
Rashmi Nisha Aurora, MD
Audrey Wells, MD
The Alloimmune Disorders of Pregnancy
Karin J. Blakemore, MD
Emilie L. Vander Haar
Escalate With Intention: Stepwise, Target-Anchored Moves
The 2-Point Signal: Apply ≥2-Point Rule
FcRn: Same Class, Different Paths—Spot Agent Differentiators
Not Just a Headache: Migraine Across Women’s Lifespan
Jelena Pavlović, MD, PhD
Amaal J. Starling, MD, FAHS, FAAN
ENDOVOICE Live: Endometriosis—A Chronic Burden of Reproductive Years
Linda Bradley, MD
Obianuju Sandra Madueke-Laveaux, MD, MPH
Lauren R. Kornegay
Diagnosing and Treating IBS: It Begins With One Simple Question
Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE
Kimberly D. Orleck, PA-C
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
Lee P. Shulman, MD, FACMG, FACOG
Samantha Denäe
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Sawsan As-Sanie, MD
James A. Simon, MD, CCD, NCMP, IF, FACOG
The IgG Clock: Redose Using IgG Kinetics
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
Clinical Considerations for the Diagnosis of Endometriosis
Pre- and Postoperative Use of GnRH Antagonists
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Melissa Simon, MD
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
Casey Joe Hinds
Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
Roberto Romero, MD, DMedSci
Loading...
We're glad to see you're enjoying Omnia Education… but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.